---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-249636"
form_type: "8-K"
ticker: "ORIC"
cik: "0001796280"
company_name: "Oric Pharmaceuticals, Inc."
filed_at: "2021-08-18T23:59:59+00:00"
generated_at: "2026-06-29T09:19:25.776671+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# SEC ends probe of ORIC CFO Piscitelli with no enforcement action

## Summary
- CFO Dominic Piscitelli received SEC subpoena in March 2020 re: trading in unrelated companies.
- On August 17, 2021, SEC informed Piscitelli investigation concluded without recommending action.
- Investigation pertained solely to personal trading of other companies, not ORIC.
- Resolution removes potential overhang for CFO and company.

## SEC filing metadata
- accession: 0001193125-21-249636
- form_type: 8-K
- ticker: ORIC
- cik: 0001796280
- company_name: Oric Pharmaceuticals, Inc.
- filed_at: 2021-08-18T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1796280/000119312521249636/0001193125-21-249636-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1796280/000119312521249636/d199524d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-249636
- JSON: https://secwatch.observer/filing/0001193125-21-249636.json
- Plain text: https://secwatch.observer/filing/0001193125-21-249636.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.